🚀 VC round data is live in beta, check it out!
Equasens Valuation Multiples
Discover revenue and EBITDA valuation multiples for Equasens and similar public comparables like Craneware, Lunit, Yidu Tech, MedicalSystem Technology and more.
Equasens Overview
About Equasens
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
Founded
1996
HQ
Employees
1.4K
Website
Financials (LTM)
EV
$747M
Equasens Financials
Equasens reported last 12-month revenue of $282M and EBITDA of $78M.
In the same LTM period, Equasens generated $78M in EBITDA and $48M in net income.
Revenue (LTM)
Equasens P&L
In the most recent fiscal year, Equasens reported revenue of $255M and EBITDA of $74M.
Equasens expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $282M | XXX | $255M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $175M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 69% | XXX | XXX | XXX |
| EBITDA | $78M | XXX | $74M | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| Net Profit | $48M | XXX | $43M | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| Net Debt | — | — | $38M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Equasens Stock Performance
Equasens has current market cap of $737M, and enterprise value of $747M.
Market Cap Evolution
Equasens' stock price is $49.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $747M | $737M | 1.5% | XXX | XXX | XXX | $2.84 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEquasens Valuation Multiples
Equasens trades at 2.6x EV/Revenue multiple, and 9.5x EV/EBITDA.
EV / Revenue (LTM)
Equasens Financial Valuation Multiples
As of April 19, 2026, Equasens has market cap of $737M and EV of $747M.
Equity research analysts estimate Equasens' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Equasens has a P/E ratio of 15.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $737M | XXX | $737M | XXX | XXX | XXX |
| EV (current) | $747M | XXX | $747M | XXX | XXX | XXX |
| EV/Revenue | 2.6x | XXX | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | 9.5x | XXX | 10.1x | XXX | XXX | XXX |
| EV/EBIT | 12.8x | XXX | 14.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.3x | XXX | XXX | XXX |
| P/E | 15.3x | XXX | 17.3x | XXX | XXX | XXX |
| EV/FCF | 14.3x | XXX | 17.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Equasens Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Equasens Margins & Growth Rates
Equasens' revenue in the last 12 month grew by 11%.
Equasens' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Equasens' rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Equasens' rule of X is 63% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Equasens Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 63% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 48% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Equasens Public Comps
See public comps and valuation multiples for other Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Equasens | XXX | XXX | XXX | XXX | XXX | XXX |
| Craneware | XXX | XXX | XXX | XXX | XXX | XXX |
| Lunit | XXX | XXX | XXX | XXX | XXX | XXX |
| Yidu Tech | XXX | XXX | XXX | XXX | XXX | XXX |
| MedicalSystem Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| HealthStream | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Equasens M&A Activity
Equasens acquired XXX companies to date.
Last acquisition by Equasens was on XXXXXXXX, XXXXX. Equasens acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Equasens
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEquasens Investment Activity
Equasens invested in XXX companies to date.
Equasens made its latest investment on XXXXXXXX, XXXXX. Equasens invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Equasens
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Equasens
| When was Equasens founded? | Equasens was founded in 1996. |
| Where is Equasens headquartered? | Equasens is headquartered in France. |
| How many employees does Equasens have? | As of today, Equasens has over 1K employees. |
| Who is the CEO of Equasens? | Equasens' CEO is Denis Supplisson. |
| Is Equasens publicly listed? | Yes, Equasens is a public company listed on Euronext Paris. |
| What is the stock symbol of Equasens? | Equasens trades under EQS ticker. |
| When did Equasens go public? | Equasens went public in 2000. |
| Who are competitors of Equasens? | Equasens main competitors are Craneware, Lunit, Yidu Tech, MedicalSystem Technology. |
| What is the current market cap of Equasens? | Equasens' current market cap is $737M. |
| What is the current revenue of Equasens? | Equasens' last 12 months revenue is $282M. |
| What is the current revenue growth of Equasens? | Equasens revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Equasens? | Current revenue multiple of Equasens is 2.6x. |
| Is Equasens profitable? | Yes, Equasens is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Equasens? | Equasens' last 12 months EBITDA is $78M. |
| What is Equasens' EBITDA margin? | Equasens' last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of Equasens? | Current EBITDA multiple of Equasens is 9.5x. |
| What is the current FCF of Equasens? | Equasens' last 12 months FCF is $52M. |
| What is Equasens' FCF margin? | Equasens' last 12 months FCF margin is 19%. |
| What is the current EV/FCF multiple of Equasens? | Current FCF multiple of Equasens is 14.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.